Stem cell imaging: from bench to bedside

PK Nguyen, J Riegler, JC Wu - Cell stem cell, 2014 - cell.com
Although cellular therapies hold great promise for the treatment of human disease, results
from several initial clinical trials have not shown a level of efficacy required for their use as a …

Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair

ME Hartman, DF Dai, MA Laflamme - Advanced drug delivery reviews, 2016 - Elsevier
Human pluripotent stem cells (PSCs) represent an attractive source of cardiomyocytes with
potential applications including disease modeling, drug discovery and safety screening, and …

Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model

J Riegler, M Tiburcy, A Ebert, E Tzatzalos… - Circulation …, 2015 - Am Heart Assoc
Rationale: Tissue engineering approaches may improve survival and functional benefits
from human embryonic stem cell–derived cardiomyocyte transplantation, thereby potentially …

Functional engineered human cardiac patches prepared from nature's platform improve heart function after acute myocardial infarction

Q Wang, H Yang, A Bai, W Jiang, X Li, X Wang, Y Mao… - Biomaterials, 2016 - Elsevier
With the advent of induced pluripotent stem cells and directed differentiation techniques, it is
now feasible to derive individual-specific cardiac cells for human heart tissue engineering …

Potential strategies to address the major clinical barriers facing stem cell regenerative therapy for cardiovascular disease: a review

PK Nguyen, E Neofytou, JW Rhee, JC Wu - JAMA cardiology, 2016 - jamanetwork.com
Importance Although progress continues to be made in the field of stem cell regenerative
medicine for the treatment of cardiovascular disease, significant barriers to clinical …

Microfluidic single-cell analysis of transplanted human induced pluripotent stem cell–derived cardiomyocytes after acute myocardial infarction

SG Ong, BC Huber, W Hee Lee, K Kodo, AD Ebert… - Circulation, 2015 - Am Heart Assoc
Background—Human induced pluripotent stem cells (iPSCs) are attractive candidates for
therapeutic use, with the potential to replace deficient cells and to improve functional …

[HTML][HTML] Tolerance induction and reversal of diabetes in mice transplanted with human embryonic stem cell-derived pancreatic endoderm

GL Szot, M Yadav, J Lang, E Kroon, J Kerr, K Kadoya… - Cell stem cell, 2015 - cell.com
Summary Type 1 diabetes (T1D) is an autoimmune disease caused by T cell-mediated
destruction of insulin-producing β cells in the islets of Langerhans. In most cases, reversal of …

Subtype-specific differentiation of cardiac pacemaker cell clusters from human induced pluripotent stem cells

PA Schweizer, FF Darche, ND Ullrich… - Stem cell research & …, 2017 - Springer
Background Human induced pluripotent stem cells (hiPSC) harbor the potential to
differentiate into diverse cardiac cell types. Previous experimental efforts were primarily …

Stem cell therapy for congenital heart disease: a systematic review

DI Tsilimigras, EK Oikonomou, D Moris, D Schizas… - Circulation, 2017 - Am Heart Assoc
Background: Congenital heart disease (CHD) constitutes the most prevalent and
heterogeneous group of congenital anomalies. Although surgery remains the gold standard …

Alloimmune responses of humanized mice to human pluripotent stem cell therapeutics

NG Kooreman, PE de Almeida, JP Stack, RV Nelakanti… - Cell reports, 2017 - cell.com
There is growing interest in using embryonic stem cell (ESC) and induced pluripotent stem
cell (iPSC) derivatives for tissue regeneration. However, an increased understanding of …